Juniper 500 mg Capsule
Natural health product licensed in Canada
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80069612
- Status
- Inactive licence
- Licence date
- 24 May 2016
- Revision date
- 18 May 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Juniperus communis Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 2,000 milligramme | 500 milligramme | Not calculated |
Non-medicinal ingredients
Maltodextrine, Gélatine, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine as a urinary tract antiseptic to help relieve benign urinary tract infections and as a diuretic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen and prior to use if you are breastfeeding.
- Contre-indications
Do not use if you are pregnant or have a kidney disorder.
Source
Official Health Canada record, licence 80069612
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging